Retatrutide is a new pharmaceutical in the fight against obesity. This novel drug, classified as a dual GLP-1 and GIP receptor agonist, demonstrates promising results in clinical trials. By activating these https://safaxesr610026.anchor-blog.com/16576496/retatrutide-a-promising-new-treatment-for-obesity